Integrating Biology for Safe Intensification of Glioblastoma Hypofractionated Treatment on the MR-Linac

Integrating Biology for Safe Intensification of Glioblastoma Hypofractionated Treatment on the MR-Linac
Conditions: High-grade Glioma

Interventions: Device: MR-Linac System; Radiation: Radiation Therapy; Drug: Temozolomide

Sponsors: NYU Langone Health

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

March 10, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments